{overleaf template gallery}LaTeX templates and examples — Recent

Things about things

山中 卓 (大阪大学 大学院理学研究科 物理学専攻)先生が作成された科研費LaTeXを、坂東 慶太 (名古屋学院大学) が了承を得てテンプレート登録しています。 詳細はこちら↓をご確認ください。 http://osksn2.hep.sci.osaka-u.ac.jp/~taku/kakenhiLaTeX/

Template for VGTC conferences from http://junctionpublishing.org/vgtc/Tasks/camera.html

This is a quick template for doing some homework. It has a heading in the upper right-hand corner. It boxes the questions and leaves the answers unboxed.

Your abstract.

Maturaarbeit Template for Matura Thesis reports at Kantonsschule Wattwil, St. Gallen, Switzerland Version 1.9

"ModernCV" CV and Cover Letter LaTeX Template Version 1.11 (19/6/14) This template has been downloaded from: http://www.LaTeXTemplates.com Original author: Xavier Danaux (xdanaux@gmail.com) License: CC BY-NC-SA 3.0 (http://creativecommons.org/licenses/by-nc-sa/3.0/)

An example LaTeX project for starting off your own article

Chronic Myeloid Leukemia is a type of cancer that starts in certain blood-forming cells of the bone marrow. Interferon-\(\alpha\) was once the standard front-line treatment producing remission rates of only 28.3 percent in 1991. After the highly effective drugs first became available in 2001, survival rates have increased immensely. According to the American Cancer Society, one large study of CML patients treated with a drug called imatinib found that about 90 percent of them were still alive 5 years after starting treatment. While imatinib has changed the way oncologists treat CML, remission is common after extended gaps in treatment. In this paper, we will explore the long-term dynamics of CML under treatment through the use of use of theoretical and mathematical components. We closely base our methods upon the approach of Urszula Ledzewicz and Helen Moore. We will introduce our unique model and explain component selections, while we move towards understanding the optimal interactions of imatinib and interferon-\(\alpha\) against dormant and proliferating CML cells. Our future work involving optimal control dynamics will be briefly introduced and further solutions are currently ongoing.